SELLAS Life Sciences Group, Inc.·4

Mar 15, 7:59 PM ET

Ghiglieri Stephen F 4

4 · SELLAS Life Sciences Group, Inc. · Filed Mar 15, 2018

Insider Transaction Report

Form 4
Period: 2018-03-13
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2018-03-13+11,00011,000 total
    Exercise: $5.24Exp: 2028-03-12Common Stock (11,000 underlying)
Footnotes (1)
  • [F1]The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Signature
Stephen F. Ghiglieri, by /s/ Ron A. Metzger, Attorney-in-Fact|2018-03-15

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION